4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-056432
Chief Financial Officer gave up 4,464 shares (to pay taxes)
- Chief Financial Officer acquired 8,789 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellemin Jean-Marc Chief Financial Officer | 2025-06-02 | Option exercise | +8,789 | 64,993 | D: show line 1 in the form | ||
| Bellemin Jean-Marc Chief Financial Officer | 2025-06-02 | Shares withheld for taxes | −4,464 | $1.76 | $7,857 | 60,529 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellemin Jean-Marc Chief Financial Officer | 2025-06-02 | Option exercise · Restricted Stock Units | −8,789 | 61,528 | D: show line 3 in the form |
Loading xslF345X05/tm2517077-1_4seq1.xml…